v3.26.1
Unaudited Condensed Consolidated Statements of Changes in Equity (Unaudited) - USD ($)
Common stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Non- controlling interest
Total
Balance at Mar. 31, 2024 $ 105 $ 43,951,069 $ (41,384,268) $ (1,672,005) $ 3,159,103 $ 4,054,004
Balance (in Shares) at Mar. 31, 2024 [1] 1,051,804          
Net (loss) income (673,420) (89,398) (762,818)
Foreign currency translation adjustments (62,320) 29,284 (33,036)
Balance at Jun. 30, 2024 $ 105 43,951,069 (42,057,688) (1,734,325) 3,098,989 3,258,150
Balance (in Shares) at Jun. 30, 2024 [1] 1,051,804          
Balance at Mar. 31, 2024 $ 105 43,951,069 (41,384,268) (1,672,005) 3,159,103 4,054,004
Balance (in Shares) at Mar. 31, 2024 [1] 1,051,804          
Net (loss) income           (1,771,649)
Foreign currency translation adjustments           (51,870)
Balance at Dec. 31, 2024 $ 105 43,951,069 (43,334,452) (1,783,267) 3,397,030 2,230,485
Balance (in Shares) at Dec. 31, 2024 [1] 1,051,804          
Balance at Jun. 30, 2024 $ 105 43,951,069 (42,057,688) (1,734,325) 3,098,989 3,258,150
Balance (in Shares) at Jun. 30, 2024 [1] 1,051,804          
Net (loss) income (711,449) 285,996 (425,453)
Foreign currency translation adjustments 93,056 26,767 119,823
Balance at Sep. 30, 2024 $ 105 43,951,069 (42,769,137) (1,641,269) 3,411,752 2,952,520
Balance (in Shares) at Sep. 30, 2024 [1] 1,051,804          
Net (loss) income (565,315) (18,063) (583,378)
Foreign currency translation adjustments (141,998) 3,341 (138,657)
Balance at Dec. 31, 2024 $ 105 43,951,069 (43,334,452) (1,783,267) 3,397,030 2,230,485
Balance (in Shares) at Dec. 31, 2024 [1] 1,051,804          
Balance at Mar. 31, 2025 $ 105 43,951,069 (45,109,573) (1,697,164) 3,203,819 348,256
Balance (in Shares) at Mar. 31, 2025 [1] 1,051,804          
Net (loss) income (164,397) (112,041) (276,438)
Exercise of November 2021 Private Placement Warrants $ 2 225,998 226,000
Exercise of November 2021 Private Placement Warrants (in Shares) [1] 20,000          
Fair value of derivative liabilities upon exercise of warrants 3,196 3,196
Conversion of preferred stock into common stock $ 4 191,417 191,421
Conversion of preferred stock into common stock (in Shares) [1] 36,471          
Additional shares of common stock round up adjustment due to retroactive effect of 1-for-10 reverse stock split  
Additional shares of common stock round up adjustment due to retroactive effect of 1-for-10 reverse stock split (in Shares) [1] 37          
Foreign currency translation adjustments (43,522) (438) (43,960)
Balance at Jun. 30, 2025 $ 111 44,371,680 (45,273,970) (1,740,686) 3,091,340 448,475
Balance (in Shares) at Jun. 30, 2025 [1] 1,108,312          
Balance at Mar. 31, 2025 $ 105 43,951,069 (45,109,573) (1,697,164) 3,203,819 348,256
Balance (in Shares) at Mar. 31, 2025 [1] 1,051,804          
Net (loss) income           (3,969,650)
Additional shares of common stock round up adjustment due to retroactive effect of 1-for-10 reverse stock split          
Issuance of common stock for consulting services $ 20 249,980 250,000
Issuance of common stock for consulting services (in Shares) [1] 200,000          
Foreign currency translation adjustments           (188,025)
Balance at Dec. 31, 2025 $ 456 45,397,481 (49,055,747) (869,464) 3,354,798 (1,172,476)
Balance (in Shares) at Dec. 31, 2025 [1] 4,557,489          
Balance at Jun. 30, 2025 $ 111 44,371,680 (45,273,970) (1,740,686) 3,091,340 448,475
Balance (in Shares) at Jun. 30, 2025 [1] 1,108,312          
Net (loss) income (648,743) (74,987) (723,730)
Exercise of November 2021 Private Placement Warrants $ 5 115,246 115,251
Exercise of November 2021 Private Placement Warrants (in Shares) [1] 53,357          
Fair value of derivative liabilities upon exercise of warrants 903 903
Cashless exercise of November 2021 Investor warrants into common stock $ 135 (135)
Cashless exercise of November 2021 Investor warrants into common stock (in Shares) [1] 1,345,820          
Foreign currency translation adjustments 26,871 157 27,028
Balance at Sep. 30, 2025 $ 251 44,487,694 (45,922,713) (1,713,815) 3,016,510 (132,073)
Balance (in Shares) at Sep. 30, 2025 [1] 2,507,489          
Net (loss) income (3,133,034) 163,552 (2,969,482)
Issuance of common stock in PIPE Offering, net of issuance costs $ 50 659,942 659,992
Issuance of common stock in PIPE Offering, net of issuance costs (in Shares) [1] 500,000          
Issuance of common stock and pre-funded warrants in registered direct offering and concurrent private placement warrants $ 135 (135)
Issuance of common stock and pre-funded warrants in registered direct offering and concurrent private placement warrants (in Shares) [1] 1,350,000          
Foreign currency translation adjustments (22,557) (148,536) (171,093)
Deconsolidation of discontinued operations 866,908 323,272 1,190,180
Balance at Dec. 31, 2025 $ 456 $ 45,397,481 $ (49,055,747) $ (869,464) $ 3,354,798 $ (1,172,476)
Balance (in Shares) at Dec. 31, 2025 [1] 4,557,489          
[1] Giving retroactive effect to the 1-for-10 reverse stock split effected on July 29, 2025